|
Volumn 86, Issue 12, 2008, Pages 1783-1788
|
2008 Update from the collaborative islet transplant r
|
Author keywords
Immunosuppression; Islet transplantation; T1 Diabetes
|
Indexed keywords
C PEPTIDE;
CALCINEURIN INHIBITOR;
DACLIZUMAB;
ETANERCEPT;
HEMOGLOBIN A1C;
INSULIN;
GLYCOSYLATED HEMOGLOBIN;
ADULT;
AGED;
ALLOTRANSPLANTATION;
ARTICLE;
AUSTRALIA;
CLINICAL PROTOCOL;
DATA ANALYSIS;
EUROPE;
GRAFT FAILURE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
IMPLANT REGISTRY;
INCIDENCE;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
MAJOR CLINICAL STUDY;
NORTH AMERICA;
ORGAN DONOR;
OUTCOME ASSESSMENT;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
THERAPY EFFECT;
CANADA;
PREDICTION AND FORECASTING;
REGISTER;
STATISTICS;
TREATMENT OUTCOME;
UNITED STATES;
ADULT;
AUSTRALIA;
CANADA;
DIABETES MELLITUS, TYPE 1;
EUROPE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
NORTH AMERICA;
PREDICTIVE VALUE OF TESTS;
REGISTRIES;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 58849102225
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/TP.0b013e3181913f6a Document Type: Article |
Times cited : (209)
|
References (6)
|